Tudor Investment Corp’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-440,001
Closed -$4.25M 3497
2024
Q3
$4.04M Buy
+440,001
New +$3.64M 0.01% 810
2023
Q4
Sell
-44,304
Closed -$817K 2891
2023
Q3
$824K Sell
44,304
-166,080
-79% -$3.88M 0.01% 1400
2023
Q2
$5.33M Buy
210,384
+88,971
+73% +$2.24M 0.06% 397
2023
Q1
$3.15M Buy
121,413
+85,362
+237% +$2.28M 0.05% 567
2022
Q4
$853K Sell
36,051
-83,538
-70% -$2.25M 0.02% 1220
2022
Q3
$3.03M Buy
119,589
+59,032
+97% +$2.07M 0.07% 384
2022
Q2
$2.01M Buy
+60,557
New +$2.57M 0.05% 509
2020
Q3
Sell
-12,761
Closed -$2.44M 1541
2020
Q2
$2.44M Buy
12,761
+4,430
+53% +$776K 0.12% 183
2020
Q1
$1.29M Sell
8,331
-29,587
-78% -$3.44M 0.12% 182
2019
Q4
$3.17M Buy
37,918
+18,353
+94% +$1.4M 0.14% 166
2019
Q3
$1.32M Buy
+19,565
New +$1.29M 0.05% 417
2019
Q1
Sell
-36,823
Closed -$1.82M 1266
2018
Q4
$1.82M Buy
36,823
+23,873
+184% +$1.46M 0.04% 220
2018
Q3
$1.12M Sell
12,950
-16,543
-56% -$1.18M 0.03% 424
2018
Q2
$1.71M Buy
+29,493
New +$1.44M 0.06% 287

Other funds holding TDOC

Tudor Investment Corp's TDOC Position: Q4 2024 in Review

Tudor Investment Corp sold out of Teladoc Health (TDOC) in Q4 2024, closing a stake of 440,001 shares — an estimated $4.25M sold.

Tudor Investment Corp first reported a position in TDOC in Q2 2018 and held it in 14 quarters. The position peaked at $5.33M in Q2 2023. 381 funds tracked by Wall St. Rank hold TDOC as of Q4 2024.

  • Tudor Investment Corp reported no remaining Teladoc Health position as of Q4 2024 after selling out during the quarter.
  • Tudor Investment Corp sold 440,001 Teladoc Health shares in Q4 2024, an estimated $4.25M.
  • Tudor Investment Corp first reported a position in Teladoc Health in Q2 2018 and held it in 14 quarters.
  • Tudor Investment Corp's Teladoc Health position peaked at $5.33M in Q2 2023.
  • 381 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2024.

Based on Tudor Investment Corp's 13F filing for Q4 2024, filed 14 Feb 2025.